Physician profile
Jon R Fox
NPI 1447221932
$2,797.64
in general payments reported to CMS, 2019-2025
24 companies · $936 in 2025
The $936 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $403 · 2022: $185 · 2023: $708 · 2024: $566 · 2025: $936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,209.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,094.10 | 2021-2025 | |
| Amgen INC. | $424.96 | 2022-2025 | Repatha, Evenity, Prolia |
| Novo Nordisk INC | $244.39 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $161.26 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $139.06 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $128.47 | 2021 | |
| Pfizer INC. | $90.27 | 2023-2025 | |
| Lilly USA, LLC | $63.70 | 2023-2025 | Zepbound, Mounjaro, Trulicity |
| Corcept Therapeutics | $59.62 | 2022-2023 | Korlym |
| Janssen Pharmaceuticals, INC | $56.71 | 2023-2024 | Spravato |
| Stryker Corporation | $40.76 | 2025 | Mako |
| Glaxosmithkline, LLC. | $39.50 | 2023-2025 | Trelegy Ellipta, Arexvy |
| Esperion Therapeutics, INC. | $38.08 | 2021 | |
| Phathom Pharmaceuticals, INC. | $30.79 | 2024-2025 | Voquezna |
| Biodelivery Sciences International, INC. | $25.76 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.80 | 2025 | Freestyle Libre 3 |
| Exeltis, USA INC. | $22.30 | 2024 | Slynd |
| Allergan, INC. | $18.53 | 2021 | |
| Daiichi Sankyo INC. | $18.16 | 2024 | Injectafer |
| Horizon Therapeutics Plc | $16.67 | 2023 | Tepezza |
| Medtronic, INC. | $16.28 | 2024 | Minimed 780g |
| Mylan Specialty L.P. | $15.61 | 2021 | |
| Hologic Sales and Service, LLC | $15.18 | 2024 | Thinprep 2000 Processor |
| Xeris Pharmaceuticals, INC. | $14.68 | 2023 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.